Related references
Note: Only part of the references are listed.A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases
Runjun Zhang et al.
BIOMATERIALS (2020)
Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases
Kye S. Kim et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo
My-Anh Nguyen et al.
ACS NANO (2019)
Nanoparticle Therapy for Vascular Diseases
Alyssa M. Flores et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Nanoparticle-Aided Characterization of Arterial Endothelial Architecture during Atherosclerosis Progression and Metabolic Therapy
Thijs J. Beldman et al.
ACS NANO (2019)
Surface Engineered Polymersomes for Enhanced Modulation of Dendritic Cells During Cardiovascular Immunotherapy
Sijia Yi et al.
ADVANCED FUNCTIONAL MATERIALS (2019)
Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species
Tina Binderup et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Drug-induced liver injury
Raul J. Andrade et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Atherosclerosis
Peter Libby et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Immunity and Inflammation in Atherosclerosis
Dennis Wolf et al.
CIRCULATION RESEARCH (2019)
An apoptotic body-biomimic liposome in situ upregulates anti-inflammatory macrophages for stabilization of atherosclerotic plaques
Yue Wu et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Bioengineered Boronic Ester Modified Dextran Polymer Nanoparticles as Reactive Oxygen Species Responsive Nanocarrier for Ischemic Stroke Treatment
Wei Lv et al.
ACS NANO (2018)
Regulatory T cells as a new therapeutic target for atherosclerosis
Han-xiao Ou et al.
ACTA PHARMACOLOGICA SINICA (2018)
Comparison of in vivo targeting ability between cRGD and collagen-targeting peptide conjugated nano-carriers for atherosclerosis
Manse Kim et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Nanoplumbers: biomaterials to fight cardiovascular diseases
Flavio Dormont et al.
MATERIALS TODAY (2018)
Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression
Yanhong Guo et al.
EBIOMEDICINE (2018)
A Targeting Nanotherapy for Abdominal Aortic Aneurysms
Juan Cheng et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Bioresponsive materials
Yue Lu et al.
NATURE REVIEWS MATERIALS (2017)
A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis
Amr Alaarg et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr-/- Mice
Mikyung Yu et al.
ADVANCED HEALTHCARE MATERIALS (2017)
Angiogenesis in the atherosclerotic plaque
Caroline Camare et al.
REDOX BIOLOGY (2017)
Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis
Yin Dou et al.
BIOMATERIALS (2017)
Biofunctional Polymer Lipid Hybrid High-Density Lipoprotein Mimicking Nanoparticles Loading Anti-miR155 for Combined Antiatherogenic Effects on Macrophages
Jing Lu et al.
BIOMACROMOLECULES (2017)
microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis
Mireille Ouimet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Fibrin-Targeted and H2O2-Responsive Nanoparticles as a Theranostics for Thrombosed Vessels
Changsun Kang et al.
ACS NANO (2017)
Vascular targeting of nanoparticles for molecular imaging of diseased endothelium
Prabhani U. Atukorale et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Non-affinity factors modulating vascular targeting of nano- and microcarriers
Jacob W. Myerson et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice
Soichi Nakashiro et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Nanoparticles responsive to the inflammatory microenvironment for targeted treatment of arterial restenosis
Shibin Feng et al.
BIOMATERIALS (2016)
Vascular Smooth Muscle Cells in Atherosclerosis
Martin R. Bennett et al.
CIRCULATION RESEARCH (2016)
MicroRNA Regulation of Atherosclerosis
Mark W. Feinberg et al.
CIRCULATION RESEARCH (2016)
Imaging the Permeable Endothelium Predicting Plaque Rupture in Atherosclerotic Rabbits
Claudia Calcagno et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2016)
Functions of microRNA-33a/b and microRNA therapeutics
Koh Ono
JOURNAL OF CARDIOLOGY (2016)
Nanomaterial-dependent immunoregulation of dendritic cells and its effects on biological activities of contraceptive nanovaccines
Pingping Xu et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice
Yin Dou et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Statin-Associated Side Effects
Paul D. Thompson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
In vitro and ex vivo strategies for intracellular delivery
Martin P. Stewart et al.
NATURE (2016)
Mechanism of hard-nanomaterial clearance by the liver
Kim M. Tsoi et al.
NATURE MATERIALS (2016)
The delivery of therapeutic oligonucleotides
Rudolph L. Juliano
NUCLEIC ACIDS RESEARCH (2016)
RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction
Hendrik B. Sager et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Multifunctional Nanoparticles Facilitate Molecular Targeting and miRNA Delivery to Inhibit Atherosclerosis in ApoE-/- Mice
Azadeh Kheirolomoom et al.
ACS NANO (2015)
MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis
Mireille Ouimet et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
SPECT/CT Imaging of High-Risk Atherosclerotic Plaques using Integrin-Binding RGD Dimer Peptides
Jung Sun Yoo et al.
SCIENTIFIC REPORTS (2015)
Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation
Jun Tang et al.
SCIENCE ADVANCES (2015)
Treating Atherosclerosis With Regulatory T Cells
Amanda C. Foks et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Nanocarriers for Vascular Delivery of Anti-Inflammatory Agents
Melissa D. Howard et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Atherosclerotic Plaque Destabilization Mechanisms, Models, and Therapeutic Strategies
Carlos Silvestre-Roig et al.
CIRCULATION RESEARCH (2014)
MicroRNA Control of High-Density Lipoprotein Metabolism and Function
Katey J. Rayner et al.
CIRCULATION RESEARCH (2014)
MicroRNA-Management of Lipoprotein Homeostasis
Xinghui Sun et al.
CIRCULATION RESEARCH (2014)
HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
Anand Rohatgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis
YongTae Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Molecular mechanisms that influence the macrophage M1-M2 polarization balance
Nan Wang et al.
FRONTIERS IN IMMUNOLOGY (2014)
Therapeutic Silencing of MicroRNA-33 Inhibits the Progression of Atherosclerosis in Ldlr-/- MiceBrief Report
Noemi Rotllan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
MicroRNA-33 in atherosclerosis etiology and pathophysiology
Wu-Jun Chen et al.
ATHEROSCLEROSIS (2013)
Cyclodextrin-derived pH-responsive nanoparticles for delivery of paclitaxel
Hongmei He et al.
BIOMATERIALS (2013)
Extracellular Acidosis Is a Novel Danger Signal Alerting Innate Immunity via the NLRP3 Inflammasome
Kristiina Rajamaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice
Takahiro Horie et al.
NATURE COMMUNICATIONS (2013)
microRNA Regulation of Inflammatory Responses
Ryan M. O'Connell et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
MicroRNA-33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE-/- Mice
Takahiro Horie et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2012)
Facile Engineering of Biocompatible Materials with pH-Modulated Degradability
Jianxiang Zhang et al.
ADVANCED MATERIALS (2011)
Understanding the linear correlation between diffusion coefficient and molecular weight. A model to estimate diffusion coefficients in acetonitrile solutions
Drochss P. Valencia et al.
ELECTROCHEMISTRY COMMUNICATIONS (2011)
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis
Katey J. Rayner et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
Katey J. Rayner et al.
NATURE (2011)
Atherosclerosis: current pathogenesis and therapeutic options
Christian Weber et al.
NATURE MEDICINE (2011)
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Mark E. Lobatto et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling
Alberto Davalos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis
S. Hani Najafi-Shoushtari et al.
SCIENCE (2010)
MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
Katey J. Rayner et al.
SCIENCE (2010)
Integrins - The keys to unlocking angiogenesis
Rita Silva et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Acetal-derivatized dextran:: An acid-responsive biodegradable material for therapeutic applications
Eric M. Bachelder et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
LANCET (2008)
Role of the integrin αVβ3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress
David R. Clemmons et al.
GROWTH HORMONE & IGF RESEARCH (2007)
ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis
Charles W. Joyce et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice
M Van Eck et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Natural regulatory T cells control the development of atherosclerosis in mice
H Ait-Oufella et al.
NATURE MEDICINE (2006)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The pH of the secretory pathway: Measurement, determinants, and regulation
P Paroutis et al.
PHYSIOLOGY (2004)
Regulation of macrophage foam cell formation by αVβ3 integrin -: Potential role in human atherosclerosis
AS Antonov et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
pH heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque
M Naghavi et al.
ATHEROSCLEROSIS (2002)
Share Paper
